PT1069912E - Formulações injectáveis de igf contendo succinato como agente tampão - Google Patents

Formulações injectáveis de igf contendo succinato como agente tampão Download PDF

Info

Publication number
PT1069912E
PT1069912E PT99916414T PT99916414T PT1069912E PT 1069912 E PT1069912 E PT 1069912E PT 99916414 T PT99916414 T PT 99916414T PT 99916414 T PT99916414 T PT 99916414T PT 1069912 E PT1069912 E PT 1069912E
Authority
PT
Portugal
Prior art keywords
igf
composition
succinate
formulations
injection
Prior art date
Application number
PT99916414T
Other languages
English (en)
Portuguese (pt)
Inventor
Bret A Shirley
Maninder S Hora
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of PT1069912E publication Critical patent/PT1069912E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT99916414T 1998-04-03 1999-04-02 Formulações injectáveis de igf contendo succinato como agente tampão PT1069912E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8000898P 1998-04-03 1998-04-03

Publications (1)

Publication Number Publication Date
PT1069912E true PT1069912E (pt) 2007-09-14

Family

ID=22154445

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99916414T PT1069912E (pt) 1998-04-03 1999-04-02 Formulações injectáveis de igf contendo succinato como agente tampão

Country Status (10)

Country Link
US (1) US20070249522A1 (cg-RX-API-DMAC7.html)
EP (1) EP1069912B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002510653A (cg-RX-API-DMAC7.html)
AT (1) ATE367828T1 (cg-RX-API-DMAC7.html)
AU (1) AU3473999A (cg-RX-API-DMAC7.html)
DE (1) DE69936638T2 (cg-RX-API-DMAC7.html)
DK (1) DK1069912T3 (cg-RX-API-DMAC7.html)
ES (1) ES2288018T3 (cg-RX-API-DMAC7.html)
PT (1) PT1069912E (cg-RX-API-DMAC7.html)
WO (1) WO1999051272A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ305123B6 (cs) 1999-10-04 2015-05-13 Novartis Vaccines And Diagnostics, Inc. Způsob výroby kapalného farmaceutického prostředku
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
EP1423509A2 (en) 2001-08-30 2004-06-02 Stem Cell Therapeutics Inc. Differentiation of neural stem cells and therapeutic use thereof
EP1430114B1 (en) 2001-09-14 2012-01-18 Stem Cell Therapeutics Inc. Prolactin induced increase in neural stem cell numbers and therapeutical use thereof
AR036402A1 (es) * 2001-09-18 2004-09-08 Stem Cell Therapeutics Inc Efecto de la hormona de crecimiento y de igf-1 sobre celulas madre neuronales.
WO2004011497A1 (en) 2002-07-31 2004-02-05 Stem Cell Therapeutics Inc. Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap)
ES2321297T3 (es) 2003-01-08 2009-06-04 Novartis Vaccines And Diagnostics, Inc. Composiciones acuosas estabilizadas que comprenden inhibidor de la via del factor tisular (ivft) o variante del inhibidor de la via del factor tisular.
KR20080074108A (ko) 2005-09-27 2008-08-12 스템 셀 테라퓨틱스 코포레이션 프로락틴에 의해 조절되는 올리고덴드로사이트 전구체 세포증식
TWI705820B (zh) * 2018-06-22 2020-10-01 美商美國禮來大藥廠 Gip/glp1促效劑組合物
EP3968979B1 (en) * 2019-05-15 2026-07-01 Bexson Biomedical, Inc. KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION
US11097023B1 (en) * 2020-07-02 2021-08-24 Par Pharmaceutical, Inc. Pre-filled syringe containing sugammadex

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa
EP0284249A1 (en) * 1987-03-13 1988-09-28 Interferon Sciences, Inc. Lyophilized lymphokine composition
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
DE68907066T2 (de) * 1988-01-29 1993-12-16 Koken Kk Verbesserte Formulierungen mit kontrollierter Abgabe.
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DK0686045T3 (da) * 1993-02-23 2001-03-05 Genentech Inc Stabilisering af med organisk opløsningsmiddel behandlede polypeptider med et hjælpestof
IT1272252B (it) * 1994-05-16 1997-06-16 Applied Research Systems Formulazioni liquide di interferone beta
TW426523B (en) * 1995-04-06 2001-03-21 Hoffmann La Roche Interferon solution
US6511811B1 (en) * 1995-06-07 2003-01-28 The Regents Of The University Of California Protein kinase C antagonist related to insulin receptor
US5977057A (en) * 1996-05-08 1999-11-02 The University Of Vermont And State Agricultural College Thrombosis prophylaxis for factor VLEIDEN carriers
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
DE19825736C2 (de) * 1997-06-11 2003-09-18 Hyundai Electronics Ind Verfahren zum Bilden eines Kondensators einer Halbleitervorrichtung
US6663899B2 (en) * 1997-06-13 2003-12-16 Genentech, Inc. Controlled release microencapsulated NGF formulation
US6887462B2 (en) * 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta

Also Published As

Publication number Publication date
DE69936638D1 (de) 2007-09-06
EP1069912A1 (en) 2001-01-24
ATE367828T1 (de) 2007-08-15
EP1069912B1 (en) 2007-07-25
DK1069912T3 (da) 2007-11-12
US20070249522A1 (en) 2007-10-25
WO1999051272A1 (en) 1999-10-14
DE69936638T2 (de) 2008-05-21
JP2002510653A (ja) 2002-04-09
AU3473999A (en) 1999-10-25
ES2288018T3 (es) 2007-12-16

Similar Documents

Publication Publication Date Title
CA2314313C (en) Stabilized teriparatide solutions
DE69233704T2 (de) Stabilisierte pharmazeutische Formulierung, umfassend Wachstumshormon und Histidin
US20070249522A1 (en) Injectable formulations containing succinate
EP2586459B1 (en) Vegf antagonist formulations
CA2252535C (en) A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent
CA2369444C (en) Pharmaceutical compositions of erythropoietin
KR20010052500A (ko) 인슐린 유사 성장 인자/인슐린 유사 성장 인자 결합단백질의 의약조성물
PT735896E (pt) Formulação de hormona paratiróide
AU2012263100A1 (en) Stable liquid formulation of etanercept
US5597802A (en) Method of formulating IGF-I with growth hormone
CA2551510C (en) Stable growth hormone liquid formulation
US20080249017A1 (en) Pharmaceutical formulations of ghrh molecules
PT96016B (pt) Processo para a preparacao de uma composicao farmaceutica para a aplicacao subcutanea ou intramuscular contendo polipeptidos
JPH08505617A (ja) インシュリン状成長因子を含有する安定溶液
WO2022106976A1 (en) Stable pharmaceutical formulations of soluble fgfr3 decoys
JP2001522814A (ja) 増大されたigf−i溶解性を提供する組成物
PT1689437E (pt) Formulação de eritropoietina em solução
MXPA06006535A (en) Stable growth hormone liquid formulation
HK1184680B (en) Vegf antagonist formulations
HK1021798B (en) Stabilized teriparatide solutions
MXPA00005655A (en) Stabilized teriparatide solutions
MXPA03008545A (es) Composiciones farmaceuticas que contienen la hormona humana del crecimiento.